Cellcura ASA
ASADissolvedOrg 980040461Uniongata 18, 3732 SkienForskning og utviklingsarbeid innen bioteknologi· NACE 72110Est. 1998 · 28 years old0 employeeshttps://www.cellcura.com
Loading company…
Overview
Cellcura ASA is a Norwegian ASA based in Skien, operating in the Forskning og utviklingsarbeid innen bioteknologi sector. Incorporated in 1998, the company has 0 employees and reported revenue of NOK 898 in its latest annual filing.
Revenue 2015
0M NOK
−100% vs 2011
EBITDA margin
−20,262,259.0 %
−762% vs 2011
Net profit 2015
-202.1M NOK
-663% vs 2011
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
-182.8 %
Very weakAmong the 10% lowest rated companies in the industry
20082015
Liquidity ratioCurrent assets ÷ Short-term debt
0.5×
Very weakAmong the 20% lowest rated companies in the industry
20082015
Return on assets (ROA)Net profit ÷ Total assets × 100
<−999 %
Very weakAmong the 10% lowest rated companies in the industry
20082015
EBITDA — year on year
NOK millionsKey figures
Annual report 2015| Revenue | 0M NOK | -100% |
| EBITDA | -182M NOK | -762% |
| Net profit | -202.1M NOK | -663% |
| Total assets | 12.6M NOK | -76% |
| Equity | -23M NOK | -166% |
| Employees | 0 | — |
Company information
Legal name
CELLCURA ASA
Org number
980040461
Legal form
Allmennaksjeselskap
NACE code
Founded
19 June 1998 · 28 years
Share capital
NOK 10,804,100
Employees
0 (FTE)
VAT registered
No
Audit selected
No
Last report
2015-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Utvikle og tilby tjenester og produkter innenfor bioteknologi og helse.
(no translation available)
Contact
Address
Uniongata 18, 3732 Skien
Website
https://www.cellcura.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2015), Cellcura ASA reported revenue of NOK 898, a decrease of 100% on the year before. The figures on this page draw on 4 annual filings covering 2008 to 2015. The bottom line showed a net loss of NOK 202.1m, and the EBITDA margin stood at -20,262,259%.
At the end of 2015, current assets covered short-term debt 0.5 times.
Financials
Revenue
NOK thousandsEBITDA
NOK millionsIncome statement
NOK thousands| Item | 2015 | 2011 | 2009 | 2008 |
|---|---|---|---|---|
| Revenue | 1 | 341 | 3 | 100 |
| Staff expenses | -135 | -3,747 | -1,160 | -2,131 |
| EBITDA | -181,955 | -21,104 | -7,250 | -19,287 |
| Depreciation & amort. | -4,190 | -5,272 | -196 | -180 |
| EBIT | -186,145 | -26,375 | -7,446 | -19,467 |
| Net financials | -15,958 | -99 | -2,967 | -2,585 |
| Profit before tax | -202,103 | -26,475 | -10,413 | -22,052 |
| Tax | -0 | -0 | -0 | -0 |
| Net profit | -202,103 | -26,475 | -10,413 | -22,052 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
NOK thousands| Item | 2015 | 2011 | 2009 | 2008 |
|---|---|---|---|---|
| Total assets | 12,595 | 53,345 | 9,365 | 5,674 |
| Equity | -23,022 | 35,045 | -26,544 | -16,131 |
| Long-term debt | 15,200 | 12,103 | 33,781 | 18,524 |
| Short-term debt | 20,417 | 5,947 | 2,128 | 3,281 |
| Total debt | 35,617 | 18,050 | 35,909 | 21,805 |
Financial ratios
5-year trendEBITDA margin
<−999 %
20082015
Equity ratio
-182.8 %
Very weakAmong the 10% lowest rated companies in the industry
20082015
Return on equity
—
20082015
Net profit margin
<−999 %
Very weakAmong the 10% lowest rated companies in the industry
20082015
Asset turnover
0.00×
WeakAmong the 30% lowest rated companies in the industry
20082015
Debt / equity
—
20082015
Sector performance
17 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginVery weak
Among the 10% lowest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginVery weak
Among the 10% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginVery weak
Among the 10% lowest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on assets (ROA)Very weak
Among the 10% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Basic earning power (BEP)Very weak
Among the 10% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioVery weak
Among the 10% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Return on equity (ROE)Not rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on net assets (RONA)Not rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Liquidity
Current ratioVery weak
Among the 20% lowest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery weak
Among the 20% lowest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery weak
Among the 10% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Cash conversion ratioWeak
Among the 40% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current assets to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Debt & solvency
Solidity ratioVery weak
Among the 10% lowest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery weak
Among the 10% lowest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Income to debtVery weak
Among the 10% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery weak
Among the 10% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageWeak
Among the 30% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Debt to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Interest rate on debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverWeak
Among the 30% lowest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Equity to contributed capitalVery weak
Among the 10% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
One-year change in equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The size of this year's increase or decrease in the company's equity.
One-year change in debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|
Former (1)
PB Chief Executive Officer | Chief Executive Officer | 2017 – 2017 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
FG Board of Directors | Board of Directors | 2016 |
DØ Chairman | Chairman | 2016 |
KG Board of Directors | Board of Directors | 2016 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 2020 |
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Dag Dvergsten As
Cellcura ASA Board network connections
Board members of Cellcura ASA also hold positions in 22 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dag Øivind Dvergsten | Chairman | 15 companiesMany roles |
| Pål Bråthen | Chief Executive Officer | 5 companies |
| Kristin Grouff Dvergsten | Board of Directors | 2 companies |
Frequently asked questions
What is the Org number of Cellcura ASA?
Cellcura ASA is registered with Brønnøysundsregistrene under Org 980040461.
What is the revenue of Cellcura ASA?
Cellcura ASA reported revenue of NOK 898 in 2015.
Who is the chairman of Cellcura ASA?
Dag Øivind Dvergsten chairs the board of Cellcura ASA, in role since 2016.
Where is Cellcura ASA headquartered?
Cellcura ASA's registered address is Uniongata 18.